Angion Biomedica is a clinical stage organ restoration biopharmaceutical company focused on renal disease.
Email Format
{first_letter_first_name}{last_name}@angion.com — 66.7%
ssmith@angion.com
{first_name}@angion.com — 33.3%
sarah@angion.com
Key Employees
Contact details of 3 Angion executives
Jay Venkatesan
-
Work email
j*y@angion.com
-
Work phone
*************1
Itzhak Goldberg
-
Work email
i*******g@angion.com
Verified
Weizhong Cai
Weizhong Cai has over 25 years of experience in thShow more...e biopharmaceutical industry. He has held various positions with increasing responsibilities, including VP for Drug Development. He has been responsible for overseeing preclinical drug development, IND filing, and clinical studies. Weizhong has a broad knowledge base in multiple disease areas. He has a great combination of strategic thinking, analytical insight and execution capabilities.
-
Work email
w**i@angion.com
-
Work phone
(************x
General Emails
General company emails, e.g. customer support lines
legal@angion.com
Legal Department
mail@angion.com
General Inquiries
affairsinvestors@angion.com
Investor Relations
bdupee@angion.com
Unclassified inbox
Similar Companies like Angion

HQ: North Chicago, Illinois, United States
AbbVie is a pharmaceutical company that discovers, develops,...
HQ: North Chicago, Illinois, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Legal Name: AbbVie Inc.
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 22, 2024
Founded Date: 2013
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NYSE:ABBV
Operating Status: Active

HQ: New York, New York, United States
Pfizer is a biopharmaceutical company that provides affordab...
HQ: New York, New York, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Legal Name: Pfizer Inc.
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 3, 2024
Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital

HQ: Rahway, New Jersey, United States
Merck is a biopharmaceutical company that offers medicines a...
HQ: Rahway, New Jersey, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Legal Name: Merck & Co., Inc.
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: 1891
Number of Exits: 9
Company Type: For Profit
Stock Symbol: NYSE:MRK
Operating Status: Active
Company Info
Last updated: 14/08/2025
5168691359
Uniondale, New York, United States
Angion General Information
Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.